Ziopharm

Ziopharm moves higher on data from preclinical study of cancer drug Ad-RTS-mIL-12

Ziopharm moves higher on data from preclinical study of cancer drug Ad-RTS-mIL-12

Yahoo/AP

3 Biotechs And The Feuerstein-Ratain Rule

3 Biotechs And The Feuerstein-Ratain Rule

Seeking Alpha

AP Pharma And Ziopharm: The Differences Between Bad News

AP Pharma And Ziopharm: The Differences Between Bad News

Seeking Alpha

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week

Motley Fool

Ziopharm cancer drug fails in late-stage trial; shares plunge

Ziopharm cancer drug fails in late-stage trial; shares plunge

Reuters

Best And Worst FDA Drug Approval Stocks of 2013

Best And Worst FDA Drug Approval Stocks of 2013

TheStreet.com

Ziopharm initiates Phase 2 study of Ad-RTLS IL-12

Ziopharm initiates Phase 2 study of Ad-RTLS IL-12

Yahoo/Fly on the Wall

Ziopharm: What Happens Next?

Ziopharm: What Happens Next?

Seeking Alpha

[video]1 Upcoming Catalyst for Ziopharm

[video]1 Upcoming Catalyst for Ziopharm

Motley Fool

3 Biotechs Burning Through Cash

3 Biotechs Burning Through Cash

Motley Fool